These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30131229)
1. Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration. Oliva F; Perna E; Marini M; Nassiacos D; Cirò A; Malfatto G; Morandi F; Caico I; Perna G; Meloni S; Vincenzi A; Villani A; Vecchi AL; Minoia C; Verde A; De Maria R; Int J Cardiol; 2018 Dec; 272():255-259. PubMed ID: 30131229 [TBL] [Abstract][Full Text] [Related]
2. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry. Dobarro D; Donoso-Trenado V; Solé-González E; Moliner-Abós C; Garcia-Pinilla JM; Lopez-Fernandez S; Ruiz-Bustillo S; Diez-Lopez C; Castrodeza J; Méndez-Fernández AB; Vaqueriza-Cubillo D; Cobo-Marcos M; Tobar J; Sagasti-Aboitiz I; Rodriguez M; Escolar V; Abecia A; Codina P; Gómez-Otero I; Pastor F; Marzoa-Rivas R; González-Babarro E; de Juan-Baguda J; Melendo-Viu M; de Frutos F; Gonzalez-Costello J ESC Heart Fail; 2023 Apr; 10(2):1193-1204. PubMed ID: 36655614 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial. Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J; Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611 [TBL] [Abstract][Full Text] [Related]
4. Intermittent infusion of inotropes in the outpatient setting: one-year post treatment analysis. López-Candales A; Carron C; Graham S; Schwartz J P R Health Sci J; 2000 Jun; 19(2):107-14. PubMed ID: 10909705 [TBL] [Abstract][Full Text] [Related]
5. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. López-Candales AL; Carron C; Schwartz J Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852 [TBL] [Abstract][Full Text] [Related]
6. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure. Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946 [TBL] [Abstract][Full Text] [Related]
7. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience. Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial. Altenberger J; Parissis JT; Costard-Jaeckle A; Winter A; Ebner C; Karavidas A; Sihorsch K; Avgeropoulou E; Weber T; Dimopoulos L; Ulmer H; Poelzl G Eur J Heart Fail; 2014 Aug; 16(8):898-906. PubMed ID: 24920349 [TBL] [Abstract][Full Text] [Related]
9. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden. Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737 [TBL] [Abstract][Full Text] [Related]
15. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. Estep JD; Starling RC; Horstmanshof DA; Milano CA; Selzman CH; Shah KB; Loebe M; Moazami N; Long JW; Stehlik J; Kasirajan V; Haas DC; O'Connell JB; Boyle AJ; Farrar DJ; Rogers JG; J Am Coll Cardiol; 2015 Oct; 66(16):1747-1761. PubMed ID: 26483097 [TBL] [Abstract][Full Text] [Related]
16. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis. Nizamic T; Murad MH; Allen LA; McIlvennan CK; Wordingham SE; Matlock DD; Dunlay SM JACC Heart Fail; 2018 Sep; 6(9):757-767. PubMed ID: 30007556 [TBL] [Abstract][Full Text] [Related]
17. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. Malfatto G; Della Rosa F; Villani A; Rella V; Branzi G; Facchini M; Parati G J Cardiovasc Pharmacol; 2012 Nov; 60(5):450-5. PubMed ID: 22932705 [TBL] [Abstract][Full Text] [Related]
18. Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients. Elsherbini H; Soliman O; Zijderhand C; Lenzen M; Hoeks SE; Kaddoura R; Izham M; Alkhulaifi A; Omar AS; Caliskan K Heart Fail Rev; 2022 Mar; 27(2):493-505. PubMed ID: 33839989 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure. Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184 [TBL] [Abstract][Full Text] [Related]
20. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]